Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Diagnosis, Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07360314
What this trial is testing

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
EMD Serono Research & Development Institute, Inc. 138
Not applicableUnknownNCT03821909
What this trial is testing

Acquisition of Portal Venous CTCs and Exosomes From Patients With Pancreatic Cancer by EUS

Who this might be right for
Pancreatic Cancer
Ying Lv 30
Testing effectiveness (Phase 2)Ended earlyNCT02711137
What this trial is testing

Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors
Incyte Corporation 137
Early research (Phase 1)Ended earlyNCT00121745
What this trial is testing

Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Epeius Biotechnologies 12
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Not applicableUnknownNCT03053999
What this trial is testing

Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)

Who this might be right for
Multiple Endocrine NeoplasiaPancreatic Neuroendocrine TumorsHyperparathyroidism
M.D. Anderson Cancer Center 53
Not applicableLooking for participantsNCT04611867
What this trial is testing

Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)

Who this might be right for
Pancreatic CancerLung Cancer, Nonsmall Cell
Inna Chen, MD 274
Not applicableActive Not RecruitingNCT06406387
What this trial is testing

ATRX/DAXX in EUS-FNB Specimens of Pan-NETs

Who this might be right for
Pancreatic Neuroendocrine Tumor
Azienda Ospedaliera Universitaria Integrata Verona 100
Early research (Phase 1)Active Not RecruitingNCT06447662
What this trial is testing

Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Who this might be right for
Carcinoma, Pancreatic DuctalColorectal NeoplasmsCarcinoma, Non-Small-Cell Lung
Pfizer 64
Early research (Phase 1)Study completedNCT01893294
What this trial is testing

Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Duct Cell Adenocarcinoma of the PancreasStage III Pancreatic CancerStage IV Pancreatic Cancer
Mayo Clinic 1
Not applicableActive Not RecruitingNCT03033927
What this trial is testing

Predicting Effective Therapy in Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Adenocarcinoma
Memorial Sloan Kettering Cancer Center 74
Early research (Phase 1)Study completedNCT00004879
What this trial is testing

Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer

Who this might be right for
Colorectal CancerEsophageal CancerKidney Cancer+3 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06172478
What this trial is testing

HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMelanomaHead and Neck Cancer+11 more
Daiichi Sankyo 740
Very early researchUnknownNCT02560376
What this trial is testing

68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis

Who this might be right for
InsulinomaNesidioblastosis
Peking Union Medical College Hospital 100
Early research (Phase 1)Ended earlyNCT02650635
What this trial is testing

TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors

Who this might be right for
Colorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Breast Carcinoma+14 more
Mayo Clinic 4
Not applicableActive Not RecruitingNCT06940778
What this trial is testing

LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA AS PRECISION MEDICINE IN GASTROINTESTINAL TUMORS

Who this might be right for
Cancer of RectumCancer of PancreasCancer of Stomach
Hospital do Coracao 273
Not applicableActive Not RecruitingNCT00582647
What this trial is testing

Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract

Who this might be right for
Esophageal CancerBile Duct NeoplasmsGastric Cancer+4 more
Memorial Sloan Kettering Cancer Center 6,000
Testing effectiveness (Phase 2)Ended earlyNCT04644315
What this trial is testing

A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

Who this might be right for
NeoplasmsColorectal NeoplasmsMelanoma+25 more
Hoffmann-La Roche 1
Early research (Phase 1)Looking for participantsNCT04678648
What this trial is testing

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmRAS MutationLung Cancer+3 more
RasCal Therapeutics, Inc. 134
Very early researchUnknownNCT04966143
What this trial is testing

Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Shanghai Longyao Biotechnology Inc., Ltd. 30
Next Page